Form4insider filings, from the source

SEC Form 4 · accession 0001213900-18-015554

ADIAL PHARMACEUTICALS, INC. · ADIL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Nov 12, 2018
Accepted (ET)
Nov 13, 2018 · 6:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513525

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant to purchase unitsF1$5.00Nov 12, 2018J20,000DJul 31, 2018Jul 31, 2023Units40,0000I
Warrant to purchase common stockF1$5.00Nov 12, 2018J20,000ANov 12, 2018Jul 31, 2023Common Stock20,00020,000I
Warrant to purchase common stockF1$6.25Nov 12, 2018J20,000ANov 12, 2018Jul 31, 2023Common Stock20,00020,000I
Warrant to purchase unitsF2$5.00Nov 12, 2018J92,000DJul 31, 2018Jul 31, 2023Units184,0000I
Warrant to purchase common stockF2$5.00Nov 12, 2018J92,000ANov 12, 2018Jul 31, 2023Common Stock92,00092,000I
Warrant to purchase common stockF2$6.25Nov 12, 2018J92,000ANov 12, 2018Jul 31, 2023Common Stock92,00092,000I

Explanation of responses